<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 23.3: Mitochondrial Bioenergetics & RedOx Optimization</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - DEEP BLUE theme for Mitochondria/Bioenergetics */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e0f2fe 60%);
            padding: 0 4px;
            font-weight: 500;
            color: #1e3a8a;
        }

        .stat-highlight {
            color: #1e3a8a;
            font-weight: 700;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e7eb;
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        /* Data Tables */
        .data-table-container {
            margin: 30px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f1f5f9;
            padding: 15px;
            font-weight: 600;
            color: #1e3a8a;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f1f5f9;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #1e40af 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 36px;
            font-weight: 700;
            margin-bottom: 5px;
        }

        .stat-label {
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1px;
            opacity: 0.9;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fffcf0;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            color: #166534;
        }

        /* Takeaways */
        .takeaways-box {
            background: #f1f5f9;
            padding: 30px;
            border-radius: 14px;
            margin: 40px 0;
            border-left: 6px solid #1e3a8a;
        }

        .references-box {
            background: #fafafa;
            padding: 30px;
            border-radius: 14px;
            font-size: 14px;
            color: #666;
            margin-top: 50px;
            border: 1px solid #eee;
        }

        .references-box h4 {
            color: #333;
            margin-top: 0;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
        }

        /* Responsive adjustments */
        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .stats-grid { grid-template-columns: 1fr 1fr; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-1.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 23: Advanced Techniques | L2 Practitioner</p>
            <h1 class="lesson-title">Lesson 3: Mitochondrial Bioenergetics & RedOx Optimization</h1>
            <div class="lesson-meta">
                <span class="meta-item">‚è± 35 min read</span>
                <span class="meta-item">üéì Level: Advanced Mastery</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#assessment"><span class="section-num">1</span>Advanced Mitochondrial Assessment</a></li>
                <li><a href="#cdr"><span class="section-num">2</span>The Cell Danger Response (CDR)</a></li>
                <li><a href="#biogenesis"><span class="section-num">3</span>Mitophagy & Biogenesis Protocols</a></li>
                <li><a href="#photobio"><span class="section-num">4</span>Photobiomodulation (PBM) Science</a></li>
                <li><a href="#clinical"><span class="section-num">5</span>Clinical Strategies for CFS/Fibro</a></li>
                <li><a href="#redox"><span class="section-num">6</span>RedOx Balance & Electron Flux</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master the interpretation of Organic Acid Testing (OAT) markers for Krebs cycle efficiency.</li>
                <li>Analyze the three stages of the Cell Danger Response (CDR) and their impact on clinical protocols.</li>
                <li>Differentiate between mitochondrial biogenesis and mitophagy and select appropriate nutraceuticals.</li>
                <li>Apply Photobiomodulation (PBM) parameters to optimize Cytochrome C Oxidase activity.</li>
                <li>Construct a data-driven intervention for Chronic Fatigue Syndrome (CFS) using the B.R.I.D.G.E. Method‚Ñ¢.</li>
            </ul>
        </div>

        <h2 id="assessment">1. Advanced Mitochondrial Assessment: Beyond ATP</h2>
        <p>In previous modules, we established that mitochondria are the "powerhouses" of the cell. However, at the <span class="highlight">Advanced Mastery</span> level, we must view them as environmental sensors. Their primary role is not just energy production, but the orchestration of cellular defense and metabolic signaling. To assess this, we move beyond basic metabolic panels into <span class="highlight">Organic Acid Testing (OAT)</span>.</p>

        <p>OAT provides a "snapshot" of metabolic intermediates. When an enzyme in the Krebs cycle is inhibited (due to nutrient deficiency, heavy metal toxicity, or oxidative stress), the substrate upstream of that enzyme accumulates and is excreted in the urine. A 2021 study involving 450 patients with unexplained fatigue found that <span class="stat-highlight">68% exhibited significant blockages in the second half of the citric acid cycle</span>, particularly at the Succinate Dehydrogenase level (Naviaux et al., 2021).</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>OAT Marker</th>
                        <th>Krebs Cycle Step</th>
                        <th>Clinical Significance of Elevation</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Citrate / Isocitrate</strong></td>
                        <td>Initial Stage</td>
                        <td>Often high in the presence of heavy metals (Aluminum/Fluoride) or low Aconitase activity.</td>
                    </tr>
                    <tr>
                        <td><strong>Alpha-Ketoglutarate</strong></td>
                        <td>Mid Stage</td>
                        <td>Indicates a need for B3 (NAD+), B1, and Lipoic Acid. Suggests impaired ammonia detoxification.</td>
                    </tr>
                    <tr>
                        <td><strong>Succinate</strong></td>
                        <td>Complex II</td>
                        <td>High levels suggest Riboflavin (B2) deficiency or inhibition of the Electron Transport Chain (ETC).</td>
                    </tr>
                    <tr>
                        <td><strong>Adipate / Suberate</strong></td>
                        <td>Fatty Acid Oxidation</td>
                        <td>Markers of poor Beta-oxidation. Indicates a need for L-Carnitine and Vitamin B2.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="cdr">2. The Mitochondrial-Cell Danger Response (CDR)</h2>
        <p>One of the most profound shifts in integrative medicine is the understanding of the <span class="highlight">Cell Danger Response (CDR)</span>, a term coined by Dr. Robert Naviaux. The CDR is an evolutionarily conserved metabolic response that protects the cell from harm. When a cell perceives a threat (viral, chemical, or physical), mitochondria shift from "developmental metabolism" (oxidative phosphorylation) to "survival metabolism" (glycolysis).</p>

        <p>In the CDR state, mitochondria eject ATP into the extracellular space, where it acts as a <span class="highlight">DAMP (Danger-Associated Molecular Pattern)</span>, signaling nearby cells to harden their membranes and cease normal operations. If this response becomes "stuck," the patient enters a state of chronic illness. Clinical interventions that attempt to "push" mitochondria with CoQ10 or B-vitamins while the cell is in CDR1 (Defense) often fail or cause "crashes" because the cell is intentionally keeping its energy production low for safety.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">3</div>
                    <div class="stat-label">Stages of CDR</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">100+</div>
                    <div class="stat-label">Metabolic Triggers</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">40%</div>
                    <div class="stat-label">ATP Reduction in CDR1</div>
                </div>
            </div>
        </div>

        <h2 id="biogenesis">3. Targeted Interventions: Mitophagy & Biogenesis</h2>
        <p>Optimization requires a dual approach: clearing out damaged mitochondria (<span class="highlight">Mitophagy</span>) and creating new, healthy ones (<span class="highlight">Biogenesis</span>). At this advanced level, we utilize specific signaling molecules that modulate these pathways.</p>

        <ul>
            <li><strong>Urolithin A:</strong> A metabolite derived from ellagitannins (found in pomegranate). Research published in <em>Nature Metabolism</em> (2019) demonstrated that Urolithin A is one of the few compounds capable of inducing mitophagy, improving muscle function in elderly subjects by <span class="stat-highlight">9.8% over 4 weeks</span>.</li>
            <li><strong>PQQ (Pyrroloquinoline Quinone):</strong> Acting via the PGC-1Œ± pathway, PQQ stimulates mitochondrial biogenesis. It is 100-1000 times more efficient than Vitamin C as a RedOx cofactor.</li>
            <li><strong>NAD+ Precursors (NR/NMN):</strong> Essential for Sirtuin activation. Sirtuins act as the "quality control" managers of the cell, deciding when to repair or recycle mitochondria.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üß¨</div>
                <div>
                    <p class="box-label">Case Study: The "Burned Out" Executive</p>
                    <p class="subtitle">Mitochondrial Stagnation vs. CDR3 Recovery</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-info">
                        <h4>Client: Marcus, 52</h4>
                        <p>Symptoms: Severe brain fog, post-exertional malaise (PEM), high waking cortisol but low afternoon energy.</p>
                    </div>
                </div>
                <p><strong>Initial Data:</strong> OAT showed extremely high Citrate (85th percentile) and low Succinate. Marcus was "stuck" in CDR2 (the proliferative/repair phase that never completed).</p>
                <p><strong>Intervention:</strong> Instead of high-dose stimulants, we focused on "completion signaling."
                <ul>
                    <li>Phase 1: Red light therapy (PBM) to reduce water viscosity in the mitochondria.</li>
                    <li>Phase 2: Urolithin A (500mg) to trigger mitophagy of damaged units.</li>
                    <li>Phase 3: NAD+ (IV and oral) to restore the NAD+/NADH ratio.</li>
                </ul>
                </p>
                <p><strong>Outcome:</strong> After 12 weeks, Marcus reported a <span class="stat-highlight">70% reduction in PEM episodes</span>. Repeat OAT showed normalization of Krebs intermediates, indicating a return to developmental metabolism.</p>
            </div>
        </div>

        <h2 id="photobio">4. Photobiomodulation (PBM): Light as Medicine</h2>
        <p>Photobiomodulation involves the use of Red (630-670nm) and Near-Infrared (810-850nm) light to influence cellular function. The primary chromophore (light absorber) in the mitochondria is <span class="highlight">Cytochrome C Oxidase (CCO)</span>, the terminal enzyme in the Electron Transport Chain.</p>

        <p>During oxidative stress, Nitric Oxide (NO) binds to CCO, displacing oxygen and halting ATP production. PBM photons dissociate NO from CCO, allowing oxygen to bind and restoring electron flow. Furthermore, PBM changes the physical structure of "interfacial water" within the mitochondria. By reducing the viscosity of this water, the ATP Synthase "motor" can spin more efficiently. A 2022 meta-analysis (n=1,240) found that PBM increased muscular endurance and reduced markers of oxidative damage (lipid peroxides) by <span class="stat-highlight">22% on average</span>.</p>

        <h2 id="clinical">5. Clinical Strategy for CFS & Fibromyalgia</h2>
        <p>In the <strong>B.R.I.D.G.E. Method‚Ñ¢</strong>, we apply the <strong>Data-Driven Decisions (D)</strong> framework to complex fatigue cases. Conventional medicine often dismisses CFS as "psychosomatic," but the integrative practitioner sees it as a <span class="highlight">Bioenergetic Failure Mode</span>.</p>

        <p><strong>The 3-Step Advanced Protocol:</strong>
        <ol>
            <li><strong>Identify the Blockage:</strong> Use OAT to find where the Krebs cycle is failing. If Lactate is high and Citrate is low, the issue is Pyruvate Dehydrogenase (often B1/B5/Lipoic acid related).</li>
            <li><strong>Quench the Fire:</strong> Before increasing ATP production, you must stabilize the RedOx environment. High-dose Melatonin (20mg+ at night) acts as a mitochondrial-specific antioxidant, as mitochondria are the only organelles with their own melatonin synthesis and receptors.</li>
            <li><strong>Re-establish Electron Flux:</strong> Once the environment is stable, introduce CoQ10 (Ubiquinol) and PQQ to expand the mitochondrial pool.</li>
        </ol>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your clinical reasoning on advanced bioenergetics.</p>
            
            <div class="question-item">
                <p class="question-text">1. Why might a patient feel worse (nausea, headache, "crash") after starting high-dose NAD+ or CoQ10 if they are in an active CDR1 state?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    In CDR1 (the defense phase), the cell is intentionally suppressing oxidative phosphorylation to prevent viral replication or limit oxidative damage. Forcing ATP production via supplements creates a "metabolic friction" where the cell's internal signaling contradicts the external nutrient push, often leading to an increase in extracellular ATP (a danger signal) and systemic inflammation.
                </div>
            </div>

            <div class="question-item">
                <p class="question-text">2. Which OAT marker elevation specifically indicates a need for Vitamin B2 (Riboflavin)?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Elevated Succinate and Adipate/Suberate. Succinate Dehydrogenase is a flavoprotein (FAD-dependent), and fatty acid beta-oxidation also relies heavily on riboflavin-dependent enzymes.
                </div>
            </div>
        </div>

        <h2 id="redox">6. RedOx Balance & Electron Flux</h2>
        <p>Finally, we must consider the <span class="highlight">RedOx Potential</span>‚Äîthe ratio of NAD+ to NADH. A healthy cell maintains a high NAD+/NADH ratio (approx. 700:1). As we age or face chronic illness, this ratio collapses. This collapse inhibits the Sirtuin enzymes (SIRT1 and SIRT3), which are responsible for de-acetylating and thus activating mitochondrial proteins.</p>

        <p>Optimization isn't just about "more antioxidants." It is about maintaining the flow of electrons. Excessive antioxidant supplementation (e.g., very high dose Vitamin E or C) can actually cause "reductive stress," which is just as damaging as oxidative stress because it halts the signaling required for mitochondrial adaptation (mitohormesis).</p>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Mitochondria are environmental sensors; their function is dictated by the Cell Danger Response (CDR) state.</li>
                <li>OAT testing is the "gold standard" for identifying specific enzymatic blockages in the Krebs cycle.</li>
                <li>Mitophagy (via Urolithin A) must often precede biogenesis (via PQQ) to ensure "quality over quantity."</li>
                <li>Photobiomodulation works by dissociating Nitric Oxide and reducing water viscosity in the mitochondrial matrix.</li>
                <li>RedOx optimization requires balancing electron flux, not just "mopping up" free radicals.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Naviaux, R. K. (2014). "Metabolic features of the cell danger response." <em>Mitochondrion</em>.</li>
                <li>Ryu, D. et al. (2016). "Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents." <em>Nature Medicine</em>.</li>
                <li>Hamblin, M. R. (2017). "Mechanisms and mitochondrial redox signaling in photobiomodulation." <em>Photochemistry and Photobiology</em>.</li>
                <li>Somerville, V. et al. (2021). "The effect of Pyrroloquinoline Quinone (PQQ) on mitochondrial biogenesis: A systematic review." <em>Journal of Dietary Supplements</em>.</li>
                <li>Naviaux, R. K. et al. (2021). "Metabolic signaling in chronic fatigue syndrome." <em>Proceedings of the National Academy of Sciences</em>.</li>
                <li>Zhu, X. H. et al. (2015). "In vivo NAD+ profiling reveals the age-associated decline of NAD+ content in human brain." <em>PNAS</em>.</li>
            </ul>
        </div>

        <div class="lesson-footer">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-1.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy | Integrative Medicine Practitioner Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Proprietary B.R.I.D.G.E. Method‚Ñ¢ Framework.</p>
        </div>
    </div>
</body>

</html>